SHSE:603392 (China)
Â
Class A
Â¥
29.2
+0.050 (+0.17%)
Jul 28
Business Description
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
ISIN : CNE100004090
Share Class Description:
SHSE:603392: Class ATotal Employee Number:
4,116Compare
Compare
Traded in other countries / regions
603392.China Index Membership
SSE Composite IndexCSI 300 Index IPO Date
2020-04-29Description
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is engaged in research, development, production, and sales of in vitro diagnostic reagents, instruments, and vaccines. The company has two segments: Diagnostic and Vaccine. The Diagnostic segment develops and sells in vitro diagnostic reagents such as ELISA, colloidal gold, biochemical, and chemiluminescent kits, along with instruments including chemiluminescent analyzers, fluorescent analyzers, and nucleic acid purification systems. The Vaccine segment focuses on products like the hepatitis E vaccine, the bivalent HPV vaccine, and the nasal spray COVID-19 vaccine. It generates the majority of its revenue from the Diagnostic segment.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 11.16 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.75 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 13.37 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -45.9 | |||||
3-Year Book Growth Rate | -1.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.4 | |||||
9-Day RSI | 52.62 | |||||
14-Day RSI | 48.86 | |||||
3-1 Month Momentum % | -33.98 | |||||
6-1 Month Momentum % | -41.54 | |||||
12-1 Month Momentum % | -56.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.21 | |||||
Quick Ratio | 3.73 | |||||
Cash Ratio | 2.48 | |||||
Days Inventory | 324.96 | |||||
Days Sales Outstanding | 320.02 | |||||
Days Payable | 163.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -0.09 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 51.3 | |||||
Operating Margin % | -18.87 | |||||
Net Margin % | -20.01 | |||||
EBITDA Margin % | -24.56 | |||||
FCF Margin % | -41.53 | |||||
OCF Margin % | -2.9 | |||||
ROE % | -3.23 | |||||
ROA % | -2.74 | |||||
ROIC % | -3.5 | |||||
3-Year ROIIC % | -185.38 | |||||
ROC (Joel Greenblatt) % | -8.59 | |||||
ROCE % | -3.84 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 587.98 | |||||
Shiller PE Ratio | 37.92 | |||||
PS Ratio | 19.09 | |||||
PB Ratio | 3.12 | |||||
Price-to-Tangible-Book | 3.41 | |||||
EV-to-EBIT | -70.21 | |||||
EV-to-EBITDA | -70.21 | |||||
EV-to-Revenue | 17.24 | |||||
EV-to-FCF | -41.52 | |||||
Price-to-GF-Value | 0.69 | |||||
Price-to-Projected-FCF | 3.08 | |||||
| Price-to-Net-Current-Asset-Value | 7.7 | |||||
| Price-to-Net-Cash | 18.25 | |||||
Earnings Yield (Greenblatt) % | -1.42 | |||||
FCF Yield % | -2.18 | |||||
Forward Rate of Return (Yacktman) % | 22.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,941.688 | ||
| EPS (TTM) (Â¥) | -0.3 | ||
| Beta | 1.2366 | ||
| 3-Year Sharpe Ratio | -0.44 | ||
| 3-Year Sortino Ratio | -0.68 | ||
| Volatility % | 23.29 | ||
| 14-Day RSI | 48.86 | ||
| 14-Day ATR (Â¥) | 1.187145 | ||
| 20-Day SMA (Â¥) | 28.592 | ||
| 12-1 Month Momentum % | -56.03 | ||
| 52-Week Range (Â¥) | 25.58 - 62.56 | ||
| Shares Outstanding (Mil) | 1,264.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| 1.4:1 Stock Split | 2023-06-05 | 67.36 (+0.33%) | ||
| 1.45:1 Stock Split | 2022-04-21 | 126.60 (-0.39%) | ||
| 1.4:1 Stock Split | 2021-05-18 | 114.95 (+0.21%) |
Show
Entries
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Frequently Asked Questions
What is Beijing Wantai Biological Pharmacy Enterprise Co Ltd(SHSE:603392)'s stock price today?
The current price of SHSE:603392 is ¥29.20. The 52 week high of SHSE:603392 is ¥62.56 and 52 week low is ¥25.58.
When is next earnings date of Beijing Wantai Biological Pharmacy Enterprise Co Ltd(SHSE:603392)?
The next earnings date of Beijing Wantai Biological Pharmacy Enterprise Co Ltd(SHSE:603392) is .
Does Beijing Wantai Biological Pharmacy Enterprise Co Ltd(SHSE:603392) pay dividends? If so, how much?
Beijing Wantai Biological Pharmacy Enterprise Co Ltd(SHSE:603392) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Beijing Wantai Biological Pharmacy Enterprise Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers